Loading
Aethlon Medical Inc Stock: price and insider trades · United States
Insider Decl.
194
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€46,378
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
US$5.16
Analyst consensus
2 analysts3.00/5
US$1.50Target US$13.25(+157%)US$25.00
Income statement
EBITDA-US$6.8M
Net income-US$7.2M0.0% margin
Valuation
PER (forward)-9.1x
P/Book0.5x
Beta1.21
Balance sheet & cash
Market capUS$8.3M
Total debtUS$336.7k
Free Cash Flow-US$7M
Debt / Equity7%
Profitability & ownership
ROE-160.9%
ROA-76.7%
% insiders3.1%
% institutions7.0%
Last declaration on 15 October 2026
Declarations194 total
436 shares@ US$6.520.030% mcap1.3% of flowCommon StockSEC:0001683168-26-007881:0
42,000 shares0Common StockSEC:0001683168-26-007901:0
436 shares@ US$6.520.030% mcap1.6% of flowCommon StockSEC:0001683168-26-007879:0
218 shares@ US$6.520.015% mcap0.7% of flowCommon StockSEC:0001683168-26-007878:0
42,000 shares0Common StockSEC:0001683168-26-007822:0
1,091 sharesCommon StockSEC:0001683168-26-005224:0
2,182 sharesCommon StockSEC:0001683168-26-005225:0
2,182 sharesCommon StockSEC:0001683168-26-005226:0
21,815 shares@ US$2.292.51% mcap31.7% of flowCommon StockSEC:0001683168-26-003114:0
21,815 shares@ US$2.292.51% mcap23.4% of flowCommon StockSEC:0001683168-26-003111:0
21,815 shares@ US$2.292.51% mcap27.2% of flowCommon StockSEC:0001683168-26-003112:0
21,815 shares@ US$2.292.51% mcap22.7% of flowCommon StockSEC:0001683168-26-003113:0
89 shares@ US$2.190.1% of flowCommon StockSEC:0001683168-26-002587:0
178 shares@ US$2.190.2% of flowCommon StockSEC:0001683168-26-002588:0
178 shares@ US$2.190.2% of flowCommon StockSEC:0001683168-26-002589:0
179 shares@ US$2.770.2% of flowCommon StockSEC:0001683168-26-000052:0
179 shares@ US$2.770.3% of flowCommon StockSEC:0001683168-26-000051:0
89 shares@ US$2.770.1% of flowCommon StockSEC:0001683168-26-000049:0
1,786 shares@ US$0.7490.6% of flowCommon StockSEC:0001683168-25-007377:0
893 shares@ US$0.7490.3% of flowCommon StockSEC:0001683168-25-007376:0
1,786 shares@ US$0.7490.7% of flowCommon StockSEC:0001683168-25-007375:0
1,786 shares@ US$1.201.0% of flowCommon StockSEC:0001683168-25-004857:0
1,786 shares@ US$1.201.2% of flowCommon StockSEC:0001683168-25-004858:0
893 shares@ US$1.200.5% of flowCommon StockSEC:0001683168-25-004859:0
142,857 shares@ US$0.3528.3% of flowCommon StockSEC:0001683168-25-002838:0
25 of 194 declarations
About Aethlon Medical Inc
Aethlon Medical Inc shows no purchase across 194 filings published from August 29, 2016 to October 15, 2026. They split into 155 grants, 30 option exercises, 6 filings of another kind and 3 sales, all by Chetan Shah, a director, on December 17, 2020: EUR 36,496, EUR 9,310 and EUR 573, EUR 46,378 in total.
Chetan Shah is also the most frequent filer with 44 filings, ahead of Edward G. Broenniman, a director (38, no sale), James B. Frakes (CFO/CEO, 22), Sabrina Martucci Johnson (18) and Nicolas Gikakis (17), also directors. Volume follows a regular curve: mostly 11 to 19 filings a year, with a high of 32 in 2020 and 31 in 2019.
Read moreShow less
The US health care company, listed on Nasdaq, is valued at USD 8.3 million, and insiders hold 3.1% of it. In the last twelve months, 18 filings were published, with no purchase or sale. The median publication delay is 2 days.
